Bennett, Julia C.; Deloria Knoll, Maria; Kagucia, Eunice W.; Garcia Quesada, Maria; Zeger, Scott L.; Hetrich, Marissa K.; Yang, Yangyupei; Herbert, Carly; Ogyu, Anju; Cohen, Adam L.; Yildirim, Inci; Winje, Brita A.; von Gottberg, Anne; Viriot, Delphine; van der Linden, Mark; Valentiner-Branth, Palle; Suga, Shigeru; Steens, Anneke; Skoczynska, Anna; Sinkovec Zorko, Nadja; Scott, J. Anthony; Savulescu, Camelia; Savrasova, Larisa; Sanz, Juan Carlos; Russell, Fiona; Ricketson, Leah J.; Puentes, Rodrigo; Nuorti, J. Pekka; Mereckiene, Jolita; McMahon, Kimberley; McGeer, Allison; Mad'arová, Lucia; Mackenzie, Grant A.; MacDonald, Laura; Lepp, Tiia; Ladhani, Shamez N.; Kristinsson, Karl G.; Kozakova, Jana; Klein, Nicola P.; Jayasinghe, Sanjay; Ho, Pak Leung; Hilty, Markus; Heyderman, Robert S.; Hasanuzzaman, Md; Hammitt, Laura L.; Guevara, Marcela; Grgic-Vitek, Marta; Gierke, Ryan; Georgakopoulou, Theano; Galloway, Yvonne (17.04.2024)
article
Background: Pneumococcal conjugate vaccines (PCVs) that are ten-valent (PCV10) and 13-valent (PCV13) became available in 2010. We evaluated their global impact on invasive pneumococcal disease (IPD) incidence in all ages. ...
